Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Healthy

Interventions

DRUG

faldaprevir

oral doses for 10 days (period B)

DRUG

Microgynon®

oral doses for 23 days (period A+B)

DRUG

BI 207127

oral doses for 10 days (period B)

Trial Locations (1)

1241.31.2 Boehringer Ingelheim Investigational Site, Mannheim